Lundbeck divests more noncore products; Recordati pays up to $100mm
Executive Summary
H. Lundbeck AS has divested the remaining ten of its noncore products to Recordati Industria Chimica & Farmaceutica SPA. Recordati paid $80mm up front, and will pay an additional $20mm upon product registration transfer.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
- Product Purchase
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice